Cargando…

Cold lymphocytotoxic antibodies in nasopharyngeal carcinoma.

Sera from patients with nasopharyngeal carcinoma (NPC), a disease associated with Epstein-Barr virus (EBV), were found to be cytotoxic at 15% degrees C in the presence of complement for a panel of human lymphocytes, with a higher frequency than those of matched controls. The cold lymphocytotoxic ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lamelin, J. P., Revillard, J. P., Chalopin, J. M., Ho, J. H., Souissi, T., Schwaab, G., De-Thé, G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1977
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025356/ https://www.ncbi.nlm.nih.gov/pubmed/192260

Ejemplares similares

Immunology: Are complement lysis and lymphocytotoxicity analogous?
por: Lachmann, P.J.
Publicado: (1983)

Potentiation of methotrexate lymphocytotoxicity in vitro by inhibitors of nucleoside transport.
por: Hughes, J. M., et al.
Publicado: (1989)

Restricted autologous lymphocytotoxicity in lung neoplasia.
por: Vose, B. M., et al.
Publicado: (1978)

Long-term survival after lymphocytotoxic monoclonal antibody therapy for rheumatoid arthritis
por: Isaacs, JD, et al.
Publicado: (2005)

In vitro generation of lymphocytotoxicity to autochthonous leukaemic cells in chronic myeloid leukaemia.
por: Khare, A. G., et al.
Publicado: (1981)

In vitro immune responses to PPD, extracts from Raji cells and nasopharyngeal carcinoma biopsies in NPC leucocytes.
por: Ng, W. S., et al.
Publicado: (1977)

Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia
Publicado: (1978)

Living donor liver transplantation using sensitized lymphocytotoxic crossmatch positive graft
por: Aoki, Taku, et al.
Publicado: (2012)

Lymphocyte subsets in tumour of patients with undifferentiated nasopharyngeal carcinoma: presence of lymphocytes with the phenotype of activated T cells.
por: Herait, P., et al.
Publicado: (1987)

The effect of a positive T-lymphocytotoxic crossmatch on clinical outcomes in adult-to-adult living donor liver transplantation
por: Kim, Young-Kyu, et al.
Publicado: (2013)

Alpha 1-microglobulin (HC protein) in human hepatocellular carcinoma.
por: Vincent, C., et al.
Publicado: (1989)

Coronavirus-associated antibodies in nasopharyngeal carcinoma and infectious mononucleosis
por: Arnold, W., et al.
Publicado: (1981)

Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinoma.
por: Ho, H. C., et al.
Publicado: (1976)

Telomerase activation in nasopharyngeal carcinomas.
por: Cheng, R. Y., et al.
Publicado: (1998)

Histocompatibility antigens controlled by the I region of the murine H- 2 complex. II. K/D region compatibility is not required for I-region cell-mediated lymphocytotoxicity
Publicado: (1977)

IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patients.
por: Ho, H. C., et al.
Publicado: (1977)

Space-time clustering of nasopharyngeal carcinoma in Greenland Eskimos.
por: Albeck, H., et al.
Publicado: (1985)

Factors affecting serum IgA antibody to Epstein-Barr viral capsid antigens in nasopharyngeal carcinoma.
por: Ho, H. C., et al.
Publicado: (1978)

Nasopharyngeal Carcinoma Metastatic to the Mandible
por: Huang, Po Hsien, et al.
Publicado: (2010)

T Cell Therapy for Nasopharyngeal Carcinoma
por: Basso, S, et al.
Publicado: (2011)

Sustained elevation of Epstein–Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma
por: Ji, M F, et al.
Publicado: (2007)

Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes.
por: Saemundsen, A. K., et al.
Publicado: (1982)

HLA and nasopharyngeal carcinoma in Malays.
por: Chan, S. H., et al.
Publicado: (1985)

Immunohistochemistry of local immunoglobulin production in nasopharyngeal carcinoma.
por: Ho, H. C., et al.
Publicado: (1978)

MOUSE THYMUS-INDEPENDENT AND THYMUS-DERIVED LYMPHOID CELLS : I. IMMUNOFLUORESCENT AND FUNCTIONAL STUDIES
por: Lamelin, J.-P., et al.
Publicado: (1972)

MOUSE THYMUS-INDEPENDENT AND THYMUS-DERIVED LYMPHOID CELLS : II. ULTRASTRUCTURAL STUDIES
por: Matter, A., et al.
Publicado: (1972)

Functional Polymorphisms and Gene Expression of TLR9 Gene as Protective Factors for Nasopharyngeal Carcinoma Severity and Progression
por: Yosra, Macherki, et al.
Publicado: (2019)

MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma
por: Chen, H-C, et al.
Publicado: (2009)

STUDIES ON THE NASOPHARYNGEAL SECRETIONS FROM PATIENTS WITH COMMON COLDS
por: Olitsky, Peter K., et al.
Publicado: (1923)

Cytogenetics of malignant epithelial cells and lymphoblastoid cell lines from nasopharyngeal carcinoma.
por: Finerty, S., et al.
Publicado: (1978)

The cadherin–catenin complex in nasopharyngeal carcinoma
por: Galera-Ruiz, H., et al.
Publicado: (2011)

The Chinese epidemiological approach of nasopharyngeal carcinoma research and control.
por: De-Thé, G.
Publicado: (1981)

Nimotuzumab, an Anti-EGFR Monoclonal Antibody, in the Treatment of Nasopharyngeal Carcinoma
por: Liang, Renba, et al.
Publicado: (2021)

Current Treatment Options for Local Residual Nasopharyngeal Carcinoma
por: Stoker, S. D., et al.
Publicado: (2013)

Incidence of nasopharyngeal carcinoma in Malaysia, 1968--1977.
por: Armstrong, R. W., et al.
Publicado: (1979)

Expression of beta-2-microglobulin by nasopharyngeal carcinoma.
por: Shiu, W., et al.
Publicado: (1992)

Locoregional radiotherapy improves survival outcomes in de novo metastatic nasopharyngeal carcinoma treated with chemoimmunotherapy
por: Hu, Y.-J., et al.
Publicado: (2023)

Nasopharyngeal Carcinoma: Etiology and Control
por: Achong, B. G.
Publicado: (1979)

Environmental and dietary risk factors for nasopharyngeal carcinoma: a case-control study in Zangwu County, Guangxi, China.
por: Zheng, Y. M., et al.
Publicado: (1994)

Methods and matrices: approaches to identifying miRNAs for Nasopharyngeal carcinoma
por: Plieskatt, Jordan L, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k59hl8pl4230b4n49ub1qjis1v